Global Primary Aldosteronism Market Research Report 2023

Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion or headaches.

The global Primary Aldosteronism market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The treatment for hyperaldosteronism depends on the underlying cause. In people with a single benign tumor (adenoma), surgical removal (adrenalectomy) may be curative. This is usually performed laparoscopically, through several very small incisions. For people with hyperplasia of both glands, successful treatment is often achieved with spironolactone or eplerenone, drugs that block the effect of aldosterone.

This report aims to provide a comprehensive presentation of the global market for Primary Aldosteronism, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Aldosteronism.

The Primary Aldosteronism market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Primary Aldosteronism market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Primary Aldosteronism companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Primary Aldosteronism Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Blood Test

1.2.3 Imaging Test

1.3 Market by Application

1.3.1 Global Primary Aldosteronism Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Specialty Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Primary Aldosteronism Market Perspective (2018-2029)

2.2 Primary Aldosteronism Growth Trends by Region

2.2.1 Global Primary Aldosteronism Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Primary Aldosteronism Historic Market Size by Region (2018-2023)

2.2.3 Primary Aldosteronism Forecasted Market Size by Region (2024-2029)

2.3 Primary Aldosteronism Market Dynamics

2.3.1 Primary Aldosteronism Industry Trends

2.3.2 Primary Aldosteronism Market Drivers

2.3.3 Primary Aldosteronism Market Challenges

2.3.4 Primary Aldosteronism Market Restraints

3.1 Global Top Primary Aldosteronism Players by Revenue

3.1.1 Global Top Primary Aldosteronism Players by Revenue (2018-2023)

3.1.2 Global Primary Aldosteronism Revenue Market Share by Players (2018-2023)

3.2 Global Primary Aldosteronism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Primary Aldosteronism Revenue

3.4 Global Primary Aldosteronism Market Concentration Ratio

3.4.1 Global Primary Aldosteronism Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Primary Aldosteronism Revenue in 2022

3.5 Primary Aldosteronism Key Players Head office and Area Served

3.6 Key Players Primary Aldosteronism Product Solution and Service

3.7 Date of Enter into Primary Aldosteronism Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Primary Aldosteronism Historic Market Size by Type (2018-2023)

4.2 Global Primary Aldosteronism Forecasted Market Size by Type (2024-2029)

5.1 Global Primary Aldosteronism Historic Market Size by Application (2018-2023)

5.2 Global Primary Aldosteronism Forecasted Market Size by Application (2024-2029)

6.1 North America Primary Aldosteronism Market Size (2018-2029)

6.2 North America Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Primary Aldosteronism Market Size by Country (2018-2023)

6.4 North America Primary Aldosteronism Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Primary Aldosteronism Market Size (2018-2029)

7.2 Europe Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Primary Aldosteronism Market Size by Country (2018-2023)

7.4 Europe Primary Aldosteronism Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Primary Aldosteronism Market Size (2018-2029)

8.2 Asia-Pacific Primary Aldosteronism Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Primary Aldosteronism Market Size by Region (2018-2023)

8.4 Asia-Pacific Primary Aldosteronism Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Primary Aldosteronism Market Size (2018-2029)

9.2 Latin America Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Primary Aldosteronism Market Size by Country (2018-2023)

9.4 Latin America Primary Aldosteronism Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Primary Aldosteronism Market Size (2018-2029)

10.2 Middle East & Africa Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Primary Aldosteronism Market Size by Country (2018-2023)

10.4 Middle East & Africa Primary Aldosteronism Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Primary Aldosteronism Introduction

11.1.4 Pfizer Revenue in Primary Aldosteronism Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Sun Pharmaceutical Industries

11.2.1 Sun Pharmaceutical Industries Company Detail

11.2.2 Sun Pharmaceutical Industries Business Overview

11.2.3 Sun Pharmaceutical Industries Primary Aldosteronism Introduction

11.2.4 Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2018-2023)

11.2.5 Sun Pharmaceutical Industries Recent Development

11.3 Bristol Laboratories

11.3.1 Bristol Laboratories Company Detail

11.3.2 Bristol Laboratories Business Overview

11.3.3 Bristol Laboratories Primary Aldosteronism Introduction

11.3.4 Bristol Laboratories Revenue in Primary Aldosteronism Business (2018-2023)

11.3.5 Bristol Laboratories Recent Development

11.4 CMP Pharma

11.4.1 CMP Pharma Company Detail

11.4.2 CMP Pharma Business Overview

11.4.3 CMP Pharma Primary Aldosteronism Introduction

11.4.4 CMP Pharma Revenue in Primary Aldosteronism Business (2018-2023)

11.4.5 CMP Pharma Recent Development

11.5 Koninklijke Philips

11.5.1 Koninklijke Philips Company Detail

11.5.2 Koninklijke Philips Business Overview

11.5.3 Koninklijke Philips Primary Aldosteronism Introduction

11.5.4 Koninklijke Philips Revenue in Primary Aldosteronism Business (2018-2023)

11.5.5 Koninklijke Philips Recent Development

11.6 GE Healthcare

11.6.1 GE Healthcare Company Detail

11.6.2 GE Healthcare Business Overview

11.6.3 GE Healthcare Primary Aldosteronism Introduction

11.6.4 GE Healthcare Revenue in Primary Aldosteronism Business (2018-2023)

11.6.5 GE Healthcare Recent Development

11.7 Siemens

11.7.1 Siemens Company Detail

11.7.2 Siemens Business Overview

11.7.3 Siemens Primary Aldosteronism Introduction

11.7.4 Siemens Revenue in Primary Aldosteronism Business (2018-2023)

11.7.5 Siemens Recent Development

11.8 Shimadzu Corporation

11.8.1 Shimadzu Corporation Company Detail

11.8.2 Shimadzu Corporation Business Overview

11.8.3 Shimadzu Corporation Primary Aldosteronism Introduction

11.8.4 Shimadzu Corporation Revenue in Primary Aldosteronism Business (2018-2023)

11.8.5 Shimadzu Corporation Recent Development

11.9 Canon

11.9.1 Canon Company Detail

11.9.2 Canon Business Overview

11.9.3 Canon Primary Aldosteronism Introduction

11.9.4 Canon Revenue in Primary Aldosteronism Business (2018-2023)

11.9.5 Canon Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Primary Aldosteronism Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Blood Test

    Table 3. Key Players of Imaging Test

    Table 4. Global Primary Aldosteronism Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Primary Aldosteronism Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Primary Aldosteronism Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Primary Aldosteronism Market Share by Region (2018-2023)

    Table 8. Global Primary Aldosteronism Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Primary Aldosteronism Market Share by Region (2024-2029)

    Table 10. Primary Aldosteronism Market Trends

    Table 11. Primary Aldosteronism Market Drivers

    Table 12. Primary Aldosteronism Market Challenges

    Table 13. Primary Aldosteronism Market Restraints

    Table 14. Global Primary Aldosteronism Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Primary Aldosteronism Market Share by Players (2018-2023)

    Table 16. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Aldosteronism as of 2022)

    Table 17. Ranking of Global Top Primary Aldosteronism Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Primary Aldosteronism Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Primary Aldosteronism Product Solution and Service

    Table 21. Date of Enter into Primary Aldosteronism Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Primary Aldosteronism Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Primary Aldosteronism Revenue Market Share by Type (2018-2023)

    Table 25. Global Primary Aldosteronism Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Primary Aldosteronism Revenue Market Share by Type (2024-2029)

    Table 27. Global Primary Aldosteronism Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Primary Aldosteronism Revenue Market Share by Application (2018-2023)

    Table 29. Global Primary Aldosteronism Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Primary Aldosteronism Revenue Market Share by Application (2024-2029)

    Table 31. North America Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Primary Aldosteronism Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Primary Aldosteronism Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Primary Aldosteronism Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Pfizer Company Detail

    Table 47. Pfizer Business Overview

    Table 48. Pfizer Primary Aldosteronism Product

    Table 49. Pfizer Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 50. Pfizer Recent Development

    Table 51. Sun Pharmaceutical Industries Company Detail

    Table 52. Sun Pharmaceutical Industries Business Overview

    Table 53. Sun Pharmaceutical Industries Primary Aldosteronism Product

    Table 54. Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 55. Sun Pharmaceutical Industries Recent Development

    Table 56. Bristol Laboratories Company Detail

    Table 57. Bristol Laboratories Business Overview

    Table 58. Bristol Laboratories Primary Aldosteronism Product

    Table 59. Bristol Laboratories Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 60. Bristol Laboratories Recent Development

    Table 61. CMP Pharma Company Detail

    Table 62. CMP Pharma Business Overview

    Table 63. CMP Pharma Primary Aldosteronism Product

    Table 64. CMP Pharma Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 65. CMP Pharma Recent Development

    Table 66. Koninklijke Philips Company Detail

    Table 67. Koninklijke Philips Business Overview

    Table 68. Koninklijke Philips Primary Aldosteronism Product

    Table 69. Koninklijke Philips Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 70. Koninklijke Philips Recent Development

    Table 71. GE Healthcare Company Detail

    Table 72. GE Healthcare Business Overview

    Table 73. GE Healthcare Primary Aldosteronism Product

    Table 74. GE Healthcare Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 75. GE Healthcare Recent Development

    Table 76. Siemens Company Detail

    Table 77. Siemens Business Overview

    Table 78. Siemens Primary Aldosteronism Product

    Table 79. Siemens Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 80. Siemens Recent Development

    Table 81. Shimadzu Corporation Company Detail

    Table 82. Shimadzu Corporation Business Overview

    Table 83. Shimadzu Corporation Primary Aldosteronism Product

    Table 84. Shimadzu Corporation Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 85. Shimadzu Corporation Recent Development

    Table 86. Canon Company Detail

    Table 87. Canon Business Overview

    Table 88. Canon Primary Aldosteronism Product

    Table 89. Canon Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million)

    Table 90. Canon Recent Development

    Table 91. Research Programs/Design for This Report

    Table 92. Key Data Information from Secondary Sources

    Table 93. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Primary Aldosteronism Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Primary Aldosteronism Market Share by Type: 2022 VS 2029

    Figure 3. Blood Test Features

    Figure 4. Imaging Test Features

    Figure 5. Global Primary Aldosteronism Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Primary Aldosteronism Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. Specialty Clinic Case Studies

    Figure 9. Others Case Studies

    Figure 10. Primary Aldosteronism Report Years Considered

    Figure 11. Global Primary Aldosteronism Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Primary Aldosteronism Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Primary Aldosteronism Market Share by Region: 2022 VS 2029

    Figure 14. Global Primary Aldosteronism Market Share by Players in 2022

    Figure 15. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Aldosteronism as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Primary Aldosteronism Revenue in 2022

    Figure 17. North America Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Primary Aldosteronism Market Share by Country (2018-2029)

    Figure 19. United States Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Primary Aldosteronism Market Share by Country (2018-2029)

    Figure 23. Germany Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Primary Aldosteronism Market Share by Region (2018-2029)

    Figure 31. China Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Primary Aldosteronism Market Share by Country (2018-2029)

    Figure 39. Mexico Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Primary Aldosteronism Market Share by Country (2018-2029)

    Figure 43. Turkey Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Pfizer Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 46. Sun Pharmaceutical Industries Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 47. Bristol Laboratories Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 48. CMP Pharma Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 49. Koninklijke Philips Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 50. GE Healthcare Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 51. Siemens Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 52. Shimadzu Corporation Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 53. Canon Revenue Growth Rate in Primary Aldosteronism Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed